参考文献/References:
[1] 余清平, 廖君, 梅志刚, 等. 基于SMAD4/Hepcidin通路探讨脑泰方对大鼠局灶性脑缺血后皮质铁代谢的神经元保护作用[J]. 中华中医药杂志, 2022,37(8): 4656-4660. YU Qingping, LIAO Jun, MEI Zhigang, et al. Neuroprotective effect of Naotai Formula on cortical iron metabolism in rats after focal cerebral ischemia based on SMAD4/hepcidin pathway[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2022,37(8): 4656-4660.
[2] 孙玙, 杨水泉, 胡朝晖, 等. 血清铁调素及铁代谢指标与脑出血早期病情及预后的相关性研究[J]. 中国临床解剖学杂志, 2021, 39(3): 355-358, 362. SUN Yu, YANG Shuiquan, HU Zhaohui, et al. Research on the serum hepcidin and iron metabolism indicator in intracerebral hemorrhage and its application in assessment of early conditions and prognosis[J].Chinese Journal of Clinical Anatomy, 2021, 39(3): 355-358, 362.
[3] BILLESB?LLE C B, AZUMAYA C M, KRETSCH R C, et al. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms[J]. Nature, 2020,586(7831): 807-811.
[4] 左二冬, 代卫, 陆晔, 等. 放疗相关性贫血患者血清Hepcidin, EPO 表达特征[J]. 现代检验医学杂志,2020, 35(2): 43-45. ZUO Erdong, DAI Wei, LU Ye, et al. Expression features of serum hepcidin and EPO in tumor patients with radiotherapy-related anemia[J]. Journal of Modern Laboratory Medicine, 2020, 35(2): 43-45.
[5] 刘丹, 吴瑾, 周红凤, 等. LncRNA MIAT 通过miR-203 调控NPAS4 促进胃癌细胞增殖、侵袭、迁移的机制研究[J]. 现代消化及介入诊疗, 2022, 27(9):1122-1128. LIU Dan, WU Jin, ZHOU Hongfeng, et al. The mechanism of LncRNA MIAT regulates NPAS4 through miR-203 to promote the proliferation, invasion and migration of gastric cancer cells[J]. Modern Digestion & Intervention, 2022, 27(9): 1122-1128.
[6] 高珊, 杜文华, 高冠起. 2 型糖尿病患者内脏脂肪面积与糖尿病周围神经病变相关性的研究[J]. 中国糖尿病杂志, 2023, 31(5): 321-324. GAO Shan, DU Wenhua, GAO Guanqi. Correlation between visceral fat area and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus[J].Chinese Journal of Diabetes, 2023, 31(5): 321-324.
[7] 中华医学会精神医学分会双相障碍协作组. 双相障碍伴混合特征临床诊治指导建议[J]. 中华精神科杂志,2018,51(2):83-89. Bipolar Disorder Collaboration Group, Chinese Association of Psychiatry, Chinese Medical Association. Recommendations of clinical diagnosis and treatment for bipolar disorder with mixed characteristics[J].Chinese Journal of Psychiatry,2018,51(2):83-89.
[8] 史欣欣, 丁荣晶, 谢稚鹃, 等. 抑郁和躯体症状量表在冠心病患者中筛查抑郁的效度和信度[J]. 中华行为医学与脑科学杂志, 2022, 31(12): 1131-1136. SHI Xinxin, DING Rongjing, XIE Zhijuan, et al. Validity and reliability of the depression and somatic symptoms scale for screening depression among patients with coronary heart disease[J]. Chinese Journal of Behavioral Medicine and Brain Science, 2022,31(12): 1131-1136.
[9] 亢何慧娴, 莫菲萍, 刘梦慧, 等. 双相障碍躁狂发作和抑郁障碍患者心理理论研究[J]. 中国神经精神疾病杂志, 2023, 49(2): 92-96. KANG Hehuixian, MO Feiping, LIU Menghui, et al. The comparison of theory of mind in the manic phase of bipolar disorder and major depressive disorder[J].Chinese Journal of Nervous and Mental Diseases, 2023,49(2): 92-96.
[10] 王威, 薄奇静, 李峰, 等. 双相障碍患者自杀的危险因素分析[J]. 国际精神病学杂志, 2021, 48(4): 640-642, 646. WANG Wei, BO Qijing, LI Feng, et al. The analysis of risk factors of suicide in bipolar disorder patients[J].Journal of International Psychiatry, 2021, 48(4): 640-642, 646.
[11] 陈东, 周娜, 张欣, 等. 广东省双相情感障碍患者危险行为的流行病学特征及其影响因素[J]. 吉林大学学报(医学版), 2021, 47(6): 1562-1569. CHEN Dong, ZHOU Na, ZHANG Xin, et al. Epidemiological characteristics and influencing factors of risk behaviors of patients with bipolar disorder in Guangdong Province[J]. Journal of Jilin University(Medicine Edition), 2021, 47(6): 1562-1569.
[12] MCINTYRE R S, PATEL M D, MASAND P S, et al. The rapid mood screener (RMS): a novel and pragmatic screener for bipolar I disorder[J].Current Medical Research and Opinion, 2021, 37(1): 135-144.
[13] SILVESTRI L, NAI A, DULJA A, et al. Hepcidin and the BMP-SMAD pathway: an unexpected liaison[J].Vitamins and Hormones, 2019, 110: 71-99.
[14] 吴迪炯, 温晓文, 刘文宾, 等. 补肾活血方对再生障碍性贫血合并铁负荷过载小鼠铁代谢的调节作用[J]. 中华中医药杂志, 2021, 36(7): 3856-3862. WU Dijiong, WEN Xiaowen, LIU Wenbin, et al. Iron metabolism regulation effect of Bushen Huoxue Formula in aplastic anemia mouse complicated with iron overload[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2021, 36(7): 3856-3862.
[15] CAMASCHELLA C, NAI A, SILVESTRI L. Iron metabolism and iron disorders revisited in the hepcidin era[J]. Haematologica, 2020, 105(2): 260-272.
[16] GINZBURG Y Z. Hepcidin-ferroportin axis in health and disease[J]. Vitamins and Hormones, 2019, 110:17-45.
[17] 都玉敏, 高莹, 安闻, 等. 颞叶癫痫幼鼠海马神经发生与Miat 及Wnt7b/β-catenin 信号通路的变化[J].儿科药学杂志, 2022, 28(10): 1-6. DU Yumin, GAO Ying, AN Wen, et al. Changes of Miat and Wnt7b/β-catenin signaling pathway in hippocampal neurogenesis of immature rats with temporal lobe epilepsy[J]. Journal of Pediatric Pharmacy, 2022, 28(10): 1-6.
[18] 何珈缘, 王清湲, 许鑫, 等. MIAT 过表达载体的构建及其对血肿瘤屏障通透性的影响[J]. 解剖科学进展, 2020, 26(1): 10-13. HE Jiayuan, WANG Qingyuan, XU Xin, et al. Construction of MIAT overexpression vector and its effect on blood tumor barrier permeability[J]. Progress of Anatomical Sciences, 2020, 26(1): 10-13.
[19] LI Dongzhe, YANG Tengyue, SHAO Chenglong, et al. LncRNA MIAT activates vascular endothelial growth factor A through RAD21 to promote nerve injury repair in acute spinal cord injury[J]. Molecular and Cellular Endocrinology, 2021, 528: 111244.
[20] 杨光, 刘雪云, 王训. 血尿素氮、肌酐及尿蛋白水平与帕金森病的相关性研究[J]. 中华神经医学杂志,2021, 20(3): 240-244. YANG Guang, LIU Xueyun, WANG Xun. Correlations of levels of blood urea nitrogen, creatinine and proteinuria with Parkinson's disease[J]. Chinese Journal of Neuromedicine, 2021, 20(3): 240-244.
[21] INKER L A, ENEANYA N D, CORESH J, et al. New creatinine - and cystatin C - based equations to estimate GFR without race[J]. New England Journal of Medicine, 2021, 385(19): 1737-1749.